OUP Management Company’s Centessa Pharmaceuticals CNTA Stock Holding History

OUP Management Company’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$19M	Hold	2,937,615	–	–	42.74%	1
2023 Q2	$18.2M	Hold	2,937,615	–	–	31.01%	1
2023 Q1	$11.3M	Hold	2,937,615	–	–	22.57%	2
2022 Q4	$9.11M	Hold	2,937,615	–	–	14.87%	2
2022 Q3	$11.8M	Hold	2,937,615	–	–	18.39%	1
2022 Q2	$14.3M	Hold	2,937,615	–	–	19.69%	1
2022 Q1	$26.4M	Buy	2,937,615 +595,724	+25%	+$5.43M	20.06%	2
2021 Q4	$26.4M	Buy	+2,341,891	New	+$31.5M	11.89%	3

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OUP Management Company's CNTA Position: Q3 2023 in Review

OUP Management Company held its Centessa Pharmaceuticals (CNTA) position steady in Q3 2023 at 2,937,615 shares worth $19M. The position accounts for 42.74% of the portfolio, ranked #1.

OUP Management Company first reported a position in CNTA in Q4 2021 and has held it in 8 quarters since. The position peaked at $26.4M in Q4 2021. 49 funds tracked by Wall St. Rank hold CNTA as of Q3 2023.

OUP Management Company held 2,937,615 shares of Centessa Pharmaceuticals worth $19M as of Q3 2023.
OUP Management Company left its Centessa Pharmaceuticals share count unchanged in Q3 2023.
Centessa Pharmaceuticals made up 42.74% of OUP Management Company's portfolio in Q3 2023, its #1 holding.
OUP Management Company first reported a position in Centessa Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
OUP Management Company's Centessa Pharmaceuticals position peaked at $26.4M in Q4 2021.
49 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.